Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nangaku, M.
Right arrow Articles by Couser, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nangaku, M.
Right arrow Articles by Couser, W. G.
J Am Soc Nephrol 13:928-936, 2002
© 2002 American Society of Nephrology

C6 Mediates Chronic Progression of Tubulointerstitial Damage in Rats with Remnant Kidneys

Masaomi Nangaku*, Jeffrey Pippin{dagger} and William G. Couser{dagger}

*Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan, and {dagger}Division of Nephrology, University of Washington Medical Center, Seattle, Washington.

Correspondence to Dr. Masaomi Nangaku, Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Phone: 81-3-5800-8648; Fax: 81-3-5800-8806; E-mail: mnangaku-tky{at}umin.ac.j

ABSTRACT. Although it was once considered only a marker of glomerular damage, accumulating evidence indicates that proteinuria per se is nephrotoxic and contributes to the progression of renal injury. Several studies have demonstrated that activation of complement in proteinuric urine results in tubular and interstitial damage. It was previously demonstrated that acute complement-mediated interstitial disease is induced by C5b-9. Here the role of C5b-9 in the progression of chronic proteinuric renal disease was investigated in a nonimmunologic remnant kidney model. Five-sixths nephrectomies were performed for normocomplementemic control and C6-deficient PVG rats. Tubulointerstitial injury was assessed by measurement of two independent markers of tubular injury (i.e., vimentin and osteopontin), interstitial accumulation of the extracellular matrix components collagen type I, collagen type IV, and laminin, interstitial macrophage infiltration, and renal function. The two groups developed similar levels of proteinuria and BP. Whereas C3 deposition on the brush border was equivalent for rats in the two groups, C5b-9 deposition was observed only for normocomplementemic rats. At day 35, the degrees of both tubulointerstitial injury and renal failure were the same for the two groups. Tubulointerstitial injury in normocomplementemic rats was still severe at day 70. In contrast, interstitial injury in C6-deficient rats had improved markedly at day 70, with improvements in renal function. In a rat model of chronic progressive renal disease secondary to nephron loss, the initial interstitial changes are complement-independent and largely reversible, whereas progressive interstitial fibrosis is mediated predominantly by C5b-9. Treatment to reduce C5b-9 attack in tubular cells may slow progression and facilitate recovery.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Gaarkeuken, M. A. Siezenga, K. Zuidwijk, C. van Kooten, T. J. Rabelink, M. R. Daha, and S. P. Berger
Complement activation by tubular cells is mediated by properdin binding
Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1397 - F1403.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Abbate, C. Zoja, D. Corna, D. Rottoli, C. Zanchi, N. Azzollini, S. Tomasoni, S. Berlingeri, M. Noris, M. Morigi, et al.
Complement-Mediated Dysfunction of Glomerular Filtration Barrier Accelerates Progressive Renal Injury
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1158 - 1167.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. S. Sheerin, P. Risley, K. Abe, Z. Tang, W. Wong, T. Lin, and S. H. Sacks
Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury
FASEB J, April 1, 2008; 22(4): 1065 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. M. Lenderink, K. Liegel, D. Ljubanovic, K. E. Coleman, G. S. Gilkeson, V. M. Holers, and J. M. Thurman
The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F555 - F564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Ozawa and H. Kobori
Crucial role of Rho-nuclear factor-{kappa}B axis in angiotensin II-induced renal injury
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F100 - F109.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Saez, M. T. Castells, A. Zuasti, F. Salazar, V. Reverte, A. Loria, and F. J. Salazar
Sex Differences in the Renal Changes Elicited by Angiotensin II Blockade During the Nephrogenic Period
Hypertension, June 1, 2007; 49(6): 1429 - 1435.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Boor, A. Konieczny, L. Villa, A.-L. Schult, E. Bucher, S. Rong, U. Kunter, C. R.C. van Roeyen, T. Polakowski, H. Hawlisch, et al.
Complement C5 Mediates Experimental Tubulointerstitial Fibrosis
J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1508 - 1515.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Abbate, C. Zoja, and G. Remuzzi
How Does Proteinuria Cause Progressive Renal Damage?
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2974 - 2984.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. A. Eddy and A. B. Fogo
Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2999 - 3012.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Nangaku
A Crry for polar shedding
Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1773 - 1775.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Ostendorf, S. Rong, P. Boor, S. Wiedemann, U. Kunter, U. Haubold, C. R.C. van Roeyen, F. Eitner, H. Kawachi, G. Starling, et al.
Antagonism of PDGF-D by Human Antibody CR002 Prevents Renal Scarring in Experimental Glomerulonephritis
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1054 - 1062.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. S. Sheerin, K. Abe, P. Risley, and S. H. Sacks
Accumulation of Immune Complexes in Glomerular Disease Is Independent of Locally Synthesized C3
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 686 - 696.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Nangaku
Chronic Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Shagdarsuren, M. Wellner, J.-H. Braesen, J.-K. Park, A. Fiebeler, N. Henke, R. Dechend, P. Gratze, F. C. Luft, and D. N. Muller
Complement Activation in Angiotensin II-Induced Organ Damage
Circ. Res., September 30, 2005; 97(7): 716 - 724.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. He, M. Imai, H. Song, R. J. Quigg, and S. Tomlinson
Complement Inhibitors Targeted to the Proximal Tubule Prevent Injury in Experimental Nephrotic Syndrome and Demonstrate a Key Role for C5b-9
J. Immunol., May 1, 2005; 174(9): 5750 - 5757.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. N. Cunningham and R. J. Quigg
Contrasting Roles of Complement Activation and Its Regulation in Membranous Nephropathy
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1214 - 1222.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Nangaku, S. J. Shankland, and W. G. Couser
Cellular Response to Injury in Membranous Nephropathy
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1195 - 1204.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Matsumoto, T. Tanaka, T. Yamamoto, E. Noiri, T. Miyata, R. Inagi, T. Fujita, and M. Nangaku
Hypoperfusion of Peritubular Capillaries Induces Chronic Hypoxia before Progression of Tubulointerstitial Injury in a Progressive Model of Rat Glomerulonephritis
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1574 - 1581.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Manotham, T. Tanaka, M. Matsumoto, T. Ohse, T. Miyata, R. Inagi, K. Kurokawa, T. Fujita, and M. Nangaku
Evidence of Tubular Hypoxia in the Early Phase in the Remnant Kidney Model
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1277 - 1288.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. A. Wilmer, B. H. Rovin, C. J. Hebert, S. V. Rao, K. Kumor, and L. A. Hebert
Management of Glomerular Proteinuria: A Commentary
J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3217 - 3232.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. Bao, J. Zhou, V. M. Holers, and R. J. Quigg
Excessive Matrix Accumulation in the Kidneys of MRL/lpr Lupus Mice Is Dependent on Complement Activation
J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2516 - 2525.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Nangaku
Complement Regulatory Proteins: Are They Important in Disease?
J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2411 - 2413.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. I-H. Hsu and W. G. Couser
Chronic Progression of Tubulointerstitial Damage in Proteinuric Renal Disease Is Mediated by Complement Activation: A Therapeutic Role for Complement Inhibitors?
J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S186 - 191.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Zoja, M. Morigi, and G. Remuzzi
Proteinuria and Phenotypic Change of Proximal Tubular Cells
J. Am. Soc. Nephrol., June 1, 2003; 14(90001): S36 - 41.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Abbate and G. Remuzzi
Can We Really Lessen Kidney Damage to the Point that the Loss of Renal Function of Progressive Nephropathy May Revert?
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1411 - 1414.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. G. Couser
Complement Inhibitors And Glomerulonephritis: Are We There Yet?
J. Am. Soc. Nephrol., March 1, 2003; 14(3): 815 - 818.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP